TYPE2 DIABETES
Clinical trials for TYPE2 DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE2 DIABETES trials appear
Sign up with your email to follow new studies for TYPE2 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes pill smooth out blood sugar after bariatric surgery?
Disease control ENROLLING_BY_INVITATIONThis study tests whether the drug dapagliflozin can reduce dangerous blood sugar highs and lows in people who have had bariatric surgery, both those with and without type 2 diabetes. About 30 participants will wear a continuous glucose monitor to track their sugar levels while ta…
Matched conditions: TYPE2 DIABETES
Phase: PHASE2 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
Intensive lifestyle program shows promise for new diabetes patients
Disease control OngoingThis study tests whether a 12-week program of very-low-calorie diet or high-intensity exercise can improve blood sugar control better than standard diabetes education. It includes 326 overweight or obese adults newly diagnosed with type 2 diabetes. The goal is to see if these lif…
Matched conditions: TYPE2 DIABETES
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Gene test: does sitagliptin work better in some people?
Knowledge-focused OngoingThis study looks at how the diabetes drug sitagliptin affects people who naturally have lower levels of a protein called DPP4 due to their genes. Researchers want to see if these individuals have better blood sugar control and higher levels of certain helpful substances compared …
Matched conditions: TYPE2 DIABETES
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Massive study reveals best Second-Line diabetes meds for heart and kidney protection
Knowledge-focused OngoingThis study looks at health records from over 780,000 people with type 2 diabetes to compare four common second-line medications: SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The goal is to see which drug class is most effective at preventing hea…
Matched conditions: TYPE2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC